Skip to content

CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes

CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02535923
Acronym
CBT-I
Enrollment
47
Registered
2015-08-31
Start date
2018-03-01
Completion date
2021-04-20
Last updated
2023-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia, Psychosis

Keywords

Schizophrenia and Disorders with Psychotic Feature, Mental Disorders, Insomnia Disorder

Brief summary

The goal of this project is to develop guidelines for the clinical tailoring of Cognitive Behavioral Therapy for Insomnia (CBT-I) for Veterans with psychotic disorders and insomnia, and to test the acceptability, feasibility, and preliminary efficacy of CBT-I for improving sleep-related functional outcomes in this population.

Detailed description

The goal of this project is to develop guidelines for the clinical tailoring of Cognitive Behavioral Therapy for Insomnia (CBT-I) for Veterans with psychotic disorders and insomnia, and to test the acceptability, feasibility, and preliminary efficacy of CBT-I for improving sleep-related functional outcomes in this population. Specific Aim 1: Develop empirically-derived guidelines for the clinical tailoring of CBT-I materials and procedures for Veterans with psychotic disorders through an iterative process with input from Veteran clients, CBT-I experts and providers, as well as those with expertise in psychotic disorders. Specific Aim 2: Establish the acceptability of CBT-I for Veterans with psychotic disorders and insomnia when delivered using guidelines developed in Specific Aim 1 in order to make further refinements to the guidelines in a preliminary trial with 6 Veterans with psychosis and insomnia. Specific Aim 3: Conduct a randomized controlled trial (n=60) to test the feasibility and preliminary efficacy of CBT-I in producing positive changes at post-treatment and 3-month follow-up on the outcomes of insomnia symptoms, sleep quality, and functioning.

Interventions

CBT-I addresses cognitive, arousal and behavioral factors related to sleep difficulties. Sessions combine assessment, conceptualization, psychoeducation, behavioral strategies and cognitive therapy, using a consistent structure including review of participants' sleep log and adherence to behavioral guidelines, modification of time in bed, cognitive therapy, and relaxation techniques. CBT-I also incorporates psychoeducation about biological and psychological elements that regulate sleep. Other strategies include stimulus control (i.e., getting out of bed when not sleepy) to extinguish the conditioned arousal common in insomnia, and relaxation techniques to reduce arousal associated with the bed, bedroom, or bedtime.

Health and Wellness is a general self-management curriculum focused on providing education and support for managing physical and emotional well-being. Each session follows a basic structure including review of previous session material, new educational information and discussion on several topics over the course of single or multiple sessions. Each session will focus on the impact of the topic on overall health and wellness, identifying benefits and challenges to improving or maintaining health in that area, and strategies that clients may find helpful to address challenges in that area. Example topics include physical activity/exercise, nutrition/healthy eating, managing medications and side effects, and addictive behaviors (e.g., substance use, gambling, eating).

Sponsors

VA Maryland Health Care System
CollaboratorFED
VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnostic and Statistical Manual of Disorders, 5th edition (DSM 5) diagnosis of schizophrenic disorders (295.0-295.9), affective psychoses (296.0-296.1, 296.4-296.8), or major depression with psychotic features (296.24, 296.34). 2. Self-reported symptoms of insomnia via an Insomnia Severity Index (ISI) score of 15 or greater. 3. Age between 18 and 80 as determined by medical record review. 4. Participation in outpatient mental health services at a designated study site. 5. Sufficient clinical stability to participate as deemed by a treatment provider. 6. Capacity to sign Informed Consent.

Exclusion criteria

1. Current problematic drug or alcohol use that impacts functioning and study engagement, as deemed by a treatment provider. 2. Currently in CBT-I treatment, determined by medical records. 3. Positive screen for sleep apnea via a portable sleep apnea screening device or a prior diagnosis of sleep apnea in medical records.

Design outcomes

Primary

MeasureTime frameDescription
Insomnia Severity Index (ISI)Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.ISI score; scored on a scale of 0 to 28, with higher scores indicating worse insomnia severity.

Secondary

MeasureTime frameDescription
Insomnia Severity Index (ISI)Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks.ISI score; scored on a scale of 0 to 28, with higher scores indicating worse insomnia severity.
Veterans RAND 36-Item Health Survey Mental Component ScoreParticipants will be assessed following completion of the study intervention, an expected average of 10 weeks.Veterans RAND 36-Item Health Survey score Mental Component Score; Possible scores range from 0 to 100, with higher scores indicating greater mental quality of life.
World Health Organization Disability Assessment Schedule (WHO-DAS), Participation in Society SubscaleParticipants will be assessed following completion of the study intervention, an expected average of 10 weeks.WHO-DAS score; scores range from 0 to 100 where 100 is full disability.

Countries

United States

Participant flow

Participants by arm

ArmCount
Cognitive Behavioral Therapy-Insomnia
Cognitive Behavioral Therapy-Insomnia: CBT-I addresses cognitive, arousal and behavioral factors related to sleep difficulties. Sessions combine assessment, conceptualization, psychoeducation, behavioral strategies and cognitive therapy, using a consistent structure including review of participants' sleep log and adherence to behavioral guidelines, modification of time in bed, cognitive therapy, and relaxation techniques. CBT-I also incorporates psychoeducation about biological and psychological elements that regulate sleep. Other strategies include stimulus control (i.e., getting out of bed when not sleepy) to extinguish the conditioned arousal common in insomnia, and relaxation techniques to reduce arousal associated with the bed, bedroom, or bedtime.
26
Health and Wellness
Health and Wellness: Health and Wellness is a general self-management curriculum focused on providing education and support for managing physical and emotional well-being. Each session follows a basic structure including review of previous session material, new educational information and discussion on several topics over the course of single or multiple sessions. Each session will focus on the impact of the topic on overall health and wellness, identifying benefits and challenges to improving or maintaining health in that area, and strategies that clients may find helpful to address challenges in that area. Example topics include physical activity/exercise, nutrition/healthy eating, managing medications and side effects, and addictive behaviors (e.g., substance use, gambling, eating).
21
Total47

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up55
Overall StudyWithdrawal by Subject43

Baseline characteristics

CharacteristicCognitive Behavioral Therapy-InsomniaHealth and WellnessTotal
Age, Continuous52.8 years
STANDARD_DEVIATION 10.6
50.4 years
STANDARD_DEVIATION 12.6
51.8 years
STANDARD_DEVIATION 11.5
Insomnia Severity Index18.7 units on a scale
STANDARD_DEVIATION 5.1
18.1 units on a scale
STANDARD_DEVIATION 5.6
18.5 units on a scale
STANDARD_DEVIATION 5.3
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
8 Participants11 Participants19 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants4 Participants7 Participants
Race (NIH/OMB)
White
15 Participants6 Participants21 Participants
Sex: Female, Male
Female
7 Participants4 Participants11 Participants
Sex: Female, Male
Male
19 Participants17 Participants36 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 260 / 21
other
Total, other adverse events
1 / 260 / 21
serious
Total, serious adverse events
0 / 260 / 21

Outcome results

Primary

Insomnia Severity Index (ISI)

ISI score; scored on a scale of 0 to 28, with higher scores indicating worse insomnia severity.

Time frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy-InsomniaInsomnia Severity Index (ISI)11.6 units on a scaleStandard Deviation 7.5
Health and WellnessInsomnia Severity Index (ISI)15.2 units on a scaleStandard Deviation 4.5
p-value: 0.04Mixed Models Analysis
p-value: 0.83Mixed Models Analysis
Secondary

Insomnia Severity Index (ISI)

ISI score; scored on a scale of 0 to 28, with higher scores indicating worse insomnia severity.

Time frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks.

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy-InsomniaInsomnia Severity Index (ISI)12.4 units on a scaleStandard Deviation 7.4
Health and WellnessInsomnia Severity Index (ISI)13.0 units on a scaleStandard Deviation 6
p-value: 0.83Mixed Models Analysis
Secondary

Veterans RAND 36-Item Health Survey Mental Component Score

Veterans RAND 36-Item Health Survey score Mental Component Score; Possible scores range from 0 to 100, with higher scores indicating greater mental quality of life.

Time frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy-InsomniaVeterans RAND 36-Item Health Survey Mental Component Score40.0 units on a scaleStandard Deviation 13.8
Health and WellnessVeterans RAND 36-Item Health Survey Mental Component Score45.5 units on a scaleStandard Deviation 10.8
p-value: 0.003Mixed Models Analysis
Secondary

Veterans RAND 36-Item Health Survey Mental Component Score

Veterans RAND 36-Item Health Survey Mental Component Score; Possible scores range from 0 to 100, with higher scores indicating greater mental health quality of life.

Time frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks.

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy-InsomniaVeterans RAND 36-Item Health Survey Mental Component Score48.4 units on a scaleStandard Deviation 12.2
Health and WellnessVeterans RAND 36-Item Health Survey Mental Component Score47.8 units on a scaleStandard Deviation 12.6
p-value: 0.16Mixed Models Analysis
Secondary

World Health Organization Disability Assessment Schedule (WHO-DAS), Participation in Society Subscale

WHO-DAS score; scores range from 0 to 100 where 100 is full disability.

Time frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy-InsomniaWorld Health Organization Disability Assessment Schedule (WHO-DAS), Participation in Society Subscale39.9 units on a scaleStandard Deviation 22.3
Health and WellnessWorld Health Organization Disability Assessment Schedule (WHO-DAS), Participation in Society Subscale34.1 units on a scaleStandard Deviation 25.8
p-value: 0.82Mixed Models Analysis
Secondary

World Health Organization Disability Assessment Schedule (WHO-DAS), Participation in Society Subscale

WHO-DAS score; scores range from 0 to 100 where 100 is full disability.

Time frame: Participants will be assessed a second time following completion of study intervention, an estimated average of 22 weeks.

ArmMeasureValue (MEAN)Dispersion
Cognitive Behavioral Therapy-InsomniaWorld Health Organization Disability Assessment Schedule (WHO-DAS), Participation in Society Subscale42.9 units on a scaleStandard Deviation 22.7
Health and WellnessWorld Health Organization Disability Assessment Schedule (WHO-DAS), Participation in Society Subscale29.6 units on a scaleStandard Deviation 15.6

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026